Lady Viviana Acosta Castillo

Dr. Lady Viviana Acosta Castillo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2026 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Jhan Sebastian Saavedra T.Jhan Sebastian Saavedra T.
Jhan Sebastian Saavedra T.
LCLady Viviana Acosta Castillo
Lady Viviana Acosta Castillo
ARAlexandra Montoya Rendon
Alexandra Montoya Rendon
DVDaniel Esteban Castro Valencia
Daniel Esteban Castro Valencia
DLDiego Alejandro Lucero
Diego Alejandro Lucero
Juan S. Izquierdo-CondoyJuan S. Izquierdo-Condoy
Juan S. Izquierdo-Condoy
Sepsis is a systemic disorder in which infection-induced inflammation progressively disrupts vascular homeostasis and drives organ dysfunction. This review reframes septic pathophysiology as a sequential and self-amplifying process centered on endothelial failure. Early activation of innate immune pathways by pathogen- and damage-associated molecular patterns promotes cytokine release, oxidative stress, and enzymatic degradation of the endothelial glycocalyx. Loss of this protective surface layer exposes endothelial cells to unbuffered inflammatory and mechanical injury, impairing mechanotransduction, increasing leukocyte and platelet adhesion, and destabilizing vascular barrier function. Subsequent disruption of intercellular junctions promotes capillary leakage, tissue edema, and impaired oxygen diffusion, while mitochondrial dysfunction and redox imbalance reduce endothelial repair capacity. In parallel, complement activation, neutrophil extracellular trap formation, platelet–leukocyte interactions, and loss of anticoagulant signaling shift the microvasculature toward a prothrombotic and proinflammatory state. These interconnected mechanisms culminate in microvascular incoherence, characterized by heterogeneous capillary flow, regional hypoxia, impaired oxygen extraction, and progressive organ failure despite apparent restoration of systemic hemodynamics. Within this framework, biomarkers such as syndecan-1, soluble thrombomodulin, angiopoietin-2, von Willebrand factor, and plasminogen activator inhibitor-1 are best interpreted as mechanistic readouts of glycocalyx shedding, endothelial injury, permeability imbalance, and thromboinflammatory activation. Understanding sepsis as an evolving endothelial pathophysiological process provides a coherent framework for integrating inflammation, vascular leakage, hypoxia, coagulation, and organ dysfunction while identifying mechanistic biomarkers that reflect distinct stages of microvascular collapse.

3 September 2024 in Hepatología
Verified
Journal Article
Open access
PDF file
KLKevin Aníbal Lloreda-Aranzazú
Kevin Aníbal Lloreda-Aranzazú
ÁMÁlvaro Andrés Montenegro-Apráez
Álvaro Andrés Montenegro-Apráez
DGDiego Mauricio Gómez-Ramírez
Diego Mauricio Gómez-Ramírez
MAMauricio Aragón-Delgado
Mauricio Aragón-Delgado
LCLady Viviana Acosta Castillo
Lady Viviana Acosta Castillo
Las miopatías inducidas por medicamentos son una causa relativamente frecuente de debilidad muscular aguda. En muchos casos, los síntomas comienzan poco después del inicio de la medicación causante; sin embargo, el diagnóstico puede ser difícil debido a la polifarmacia o a la asociación inicial de los síntomas con otras patologías. Esto puede provocar un retraso en la retirada del medicamento, lo cual es fundamental para el tratamiento. Se presenta el caso de un paciente de 62 años de edad con antecedentes de hepatocarcinoma, quien presentó debilidad muscular aguda en el posoperatorio de un trasplante hepático temprano. Se documentó una asociación excepcional con miopatía inducida por micofenolato. Tras suspender este fármaco, el paciente recuperó completamente la fuerza muscular, confirmando así el diagnóstico. De hecho, este caso es el segundo reportado en la literatura médica sobre miopatía inducida por micofenolato.